The company is developing a pilot facility for algae biomass production in Western Australia.
Aurora Algae (Hayward, CA) has secured a $2 million LEED grant from the Australian State Government to develop a pilot algae production facility in Western Australia.
Using CO2 from nearby industrial producers as feedstock, Aurora Algae’s facility is expected to produce between 12 and 15 metric tons of algae biomass each month. That algae can then be sold across several markets, including nutraceuticals, pharmaceuticals, aquaculture, and renewable energy. Commercial-scale production is anticipated for mid-2014.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.